EPISODE · Mar 29, 2021 · 14 MIN
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
from Diabetes Discourse
Host: John Buse, MD, PhD Guest: Anne Louise Peters, MD SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.
Embed this episode
NOW PLAYING
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
0:00
14:29
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Diabetes Discourse?
This episode is 14 minutes long.
When was this Diabetes Discourse episode published?
This episode was published on March 29, 2021.
Can I download this Diabetes Discourse episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!